DERM Journey Medical Corp — earnings, filings & institutional moves

Price chart

Daily historical data with per-account defaults

Latest close

$5.97

Period return

-2.23 (-27.20%)

Volume

116.4K

2026-06-05O $6.14 H $6.16 L $5.93 C $5.97MA5 $6.07MA20 $5.93MA60 $5.69MA120 $6.89

6M · 124 barsYahoo Finance · USD2025-12-08 → 2026-06-05

Recent event timeline

Filings, earnings, research, and institutional changes — newest first

View all →

2026. 03. 26.LowBUY2 months ago
HC Wainwright & Co.: Buy
US analyst rating / recommendation change.
2025. 08. 25.MediumBUY10 months ago
HC Wainwright & Co.: Buy
US analyst rating / recommendation change.
2025. 08. 14.LowBUY10 months ago
Lake Street: Buy
US analyst rating / recommendation change.

Recent earnings

Consensus vs. actual, and revenue trend

Earnings tab →

Research actions

Consensus PT $13.5 · 4 analysts

Research tab →

AI Brief (Premium)

Automated summary from public sources · not investment advice

Brief tab →

No AI brief generated yet. You can create one from the Brief tab.

Top institutions (13F)

Ranked by position value

Institutions tab →

Company info

Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also provides Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Emrosi for the treatment of inflammatory lesions of rosacea; Exelderm cream and solution for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
HQ

2025. 07. 31.LowBUY10 months ago

B. Riley Securities: Buy